Laboratory Medicine ›› 2017, Vol. 32 ›› Issue (12): 1121-1123.DOI: 10.3969/j.issn.1673-8640.2017.12.011
• Orginal Article • Previous Articles Next Articles
Received:2017-04-26
Online:2017-12-30
Published:2018-01-10
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2017.12.011
| 组别 | 例数 | TC（mmol/L） | LDL-C（mmol/L） | HDL-C（mmol/L） | ox-LDL（mg/L） |
|---|---|---|---|---|---|
| 肾细胞癌组 | 138 | 4.97±0.78* | 3.57±0.60* | 1.14±0.24* | 9.21±0.52* |
| 正常对照组 | 138 | 4.19±0.76 | 2.64±0.62 | 1.57±0.29 | 7.56±0.75 |
| 组别 | 例数 | TC（mmol/L） | LDL-C（mmol/L） | HDL-C（mmol/L） | ox-LDL（mg/L） |
|---|---|---|---|---|---|
| 肾细胞癌组 | 138 | 4.97±0.78* | 3.57±0.60* | 1.14±0.24* | 9.21±0.52* |
| 正常对照组 | 138 | 4.19±0.76 | 2.64±0.62 | 1.57±0.29 | 7.56±0.75 |
| 组别 | 例数 | ox-LDL |
|---|---|---|
| 肾细胞癌1级组 | ||
| 治疗前 | 42 | 7.89±0.34 |
| 治疗后 | 42 | 7.08±0.41△ |
| 肾细胞癌2级组 | ||
| 治疗前 | 49 | 8.95±0.57* |
| 治疗后 | 49 | 7.85±0.52*△ |
| 肾细胞癌3级组 | ||
| 治疗前 | 47 | 9.83±0.79*# |
| 治疗后 | 47 | 8.51±0.67*#△ |
| 组别 | 例数 | ox-LDL |
|---|---|---|
| 肾细胞癌1级组 | ||
| 治疗前 | 42 | 7.89±0.34 |
| 治疗后 | 42 | 7.08±0.41△ |
| 肾细胞癌2级组 | ||
| 治疗前 | 49 | 8.95±0.57* |
| 治疗后 | 49 | 7.85±0.52*△ |
| 肾细胞癌3级组 | ||
| 治疗前 | 47 | 9.83±0.79*# |
| 治疗后 | 47 | 8.51±0.67*#△ |
| [1] | 陈祝俊,张拥黎,卢仁泉,等. 血浆氧化型低密度脂蛋白检测在肾细胞癌诊治中的临床意义[J]. 中国肿瘤,2016,25(5):400-403. |
| [2] | 于路平,张春芳,郝一昌,等. 代谢相关因素与肾癌发病风险的相关性研究[J]. 中华泌尿外科杂志,2013,34(3):179-183. |
| [3] | NALINI N,MANJU V,MENON V P.Effect of spices on lipid metabolism in 1,2-dimethylhydrazine-induced rat colon carcinogenesis[J]. J Med Food,2006,9(2):237-245. |
| [4] | HERBEY I I,IVANKOVA N V,KATKOORI V R,et al.Colorectal cancer and hypercholesterolemia: review of current research[J]. Exp Oncol,2005,27(3):166-178. |
| [5] | 张涛,欧阳新平,何平平,等. 肾癌与血浆脂代谢指标水平相关性分析[J]. 临床和实验医学杂志,2013,12(23):1916-1918. |
| [6] | DELIMARIS I, FAVIOU E, ANTONAKOS G,et al.Oxidized LDL,serum oxidizability and serum lipid levels in patients with breast or ovarian cancer[J]. Clin Biochem,2007,40(15):1129-1134. |
| [7] | WAN F,QIN X,ZHANG G,et al.Oxidized low-density lipoprotein is associated with advanced-stage prostate cancer[J]. Tumor Biol,2015,36(5):3573-3582. |
| [8] | SUZUKI K,ITO Y,WAKAI K,et al.Serum oxidized low-density lipoprotein levels and risk of colorectal cancer:a case-control study nested in the Japan Collaborative Cohort Study[J]. Cancer Epidemiol Biomarkers Prev,2004,13(11 Pt 1):1781-1787. |
| [1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
| [2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
| [3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
| [4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
| [5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
| [6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
| [7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
| [8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
| [9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
| [10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
| [11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
| [12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
| [15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
